{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:28:16Z","timestamp":1787592496848,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/cdd.2016.146","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T15:39:02Z","timestamp":1483717142000},"page":"445-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway"],"prefix":"10.1038","volume":"24","author":[{"given":"Yi-Jun","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Fa","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-An","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"BFcdd2016146_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","volume":"21","author":"XS Wu","year":"2014","unstructured":"Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol 2014; 21: 449\u2013457.","journal-title":"Ann Surg Oncol"},{"key":"BFcdd2016146_CR2","doi-asserted-by":"publisher","first-page":"e0114851","DOI":"10.1371\/journal.pone.0114851","volume":"10","author":"TY Liu","year":"2015","unstructured":"Liu TY, Gong W, Tan ZJ, Lu W, Wu XS, Weng H et al. Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX. PloS One 2015; 10: e0114851.","journal-title":"PloS One"},{"key":"BFcdd2016146_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet 2014; 46: 872\u2013876.","journal-title":"Nat Genet"},{"key":"BFcdd2016146_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-14-566","volume":"14","author":"YJ Shu","year":"2014","unstructured":"Shu YJ, Weng H, Bao RF, Wu XS, Ding Q, Cao Y et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer 2014; 14: 566.","journal-title":"BMC Cancer"},{"key":"BFcdd2016146_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I . MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 2015; 5: 1122\u20131143.","journal-title":"Theranostics"},{"key":"BFcdd2016146_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843\u2013854.","journal-title":"Cell"},{"key":"BFcdd2016146_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","volume":"75","author":"B Wightman","year":"1993","unstructured":"Wightman B, Ha I, Ruvkun G . Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855\u2013862.","journal-title":"Cell"},{"key":"BFcdd2016146_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jhep.2015.05.008","volume":"63","author":"F Fang","year":"2015","unstructured":"Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H et al. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J Hepatol 2015; 63: 874\u2013885.","journal-title":"J Hepatol"},{"key":"BFcdd2016146_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jhep.2013.10.028","volume":"60","author":"L Xu","year":"2014","unstructured":"Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A et al. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J Hepatol 2014; 60: 590\u2013598.","journal-title":"J Hepatol"},{"key":"BFcdd2016146_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jhep.2013.04.034","volume":"59","author":"Y Chang","year":"2013","unstructured":"Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J et al. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol 2013; 59: 518\u2013527.","journal-title":"J Hepatol"},{"key":"BFcdd2016146_CR11","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.18632\/oncotarget.3089","volume":"6","author":"J Jiang","year":"2015","unstructured":"Jiang J, Yu C, Chen M, Zhang H, Tian S, Sun C . Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Oncotarget 2015; 6: 2767\u20132778.","journal-title":"Oncotarget"},{"key":"BFcdd2016146_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2011.06.191","volume":"411","author":"CM Wang","year":"2011","unstructured":"Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG et al. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011; 411: 586\u2013592.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd2016146_CR13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.27200","volume":"60","author":"S Parpart","year":"2014","unstructured":"Parpart S, Roessler S, Dong F, Rao V, Takai A, Ji J et al. Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome. Hepatology 2014; 60: 872\u2013883.","journal-title":"Hepatology"},{"key":"BFcdd2016146_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mrfmmm.2009.11.004","volume":"684","author":"NE Landvik","year":"2010","unstructured":"Landvik NE, Arlt VM, Nagy E, Solhaug A, Tekpli X, Schmeiser HH et al. 3-Nitrobenzanthrone and 3-aminobenzanthrone induce DNA damage and cell signalling in Hepa1c1c7 cells. Mutat Res 2010; 684: 11\u201323.","journal-title":"Mutat Res"},{"key":"BFcdd2016146_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/sj.emboj.7601652","volume":"26","author":"Y Inoue","year":"2007","unstructured":"Inoue Y, Kitagawa M, Taya Y . Phosphorylation of pRB at Ser612 by Chk1\/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 2007; 26: 2083\u20132093.","journal-title":"EMBO J"},{"key":"BFcdd2016146_CR16","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-14-0485","volume":"20","author":"H Wang","year":"2014","unstructured":"Wang H, Shi J, Luo Y, Liao Q, Niu Y, Zhang F et al. LIM and SH3 protein 1 induces TGFbeta-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. Clin Cancer Res 2014; 20: 5835\u20135847.","journal-title":"Clin Cancer Res"},{"key":"BFcdd2016146_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1248\/bpb.b12-00197","volume":"35","author":"Y Liu","year":"2012","unstructured":"Liu Y, Shi QF, Qi M, Tashiro S, Onodera S, Ikejima T . Interruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer A549 cells via c-met-nuclear factor-kappaB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathways. Biol Pharm Bull 2012; 35: 1150\u20131158.","journal-title":"Biol Pharm Bull"},{"key":"BFcdd2016146_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tox.2011.03.006","volume":"283","author":"S Pal","year":"2011","unstructured":"Pal S, Pal PB, Das J, Sil PC . Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology 2011; 283: 129\u2013139.","journal-title":"Toxicology"},{"key":"BFcdd2016146_CR19","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4161\/cc.6.18.4728","volume":"6","author":"KE Ewings","year":"2007","unstructured":"Ewings KE, Wiggins CM, Cook SJ . Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 2007; 6: 2236\u20132240.","journal-title":"Cell Cycle"},{"key":"BFcdd2016146_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1476-4598-3-36","volume":"3","author":"A Das","year":"2004","unstructured":"Das A, Banik NL, Patel SJ, Ray SK . Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 2004; 3: 36.","journal-title":"Mol Cancer"},{"key":"BFcdd2016146_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nsmb.1533","volume":"16","author":"SY Park","year":"2009","unstructured":"Park SY, Lee JH, Ha M, Nam JW, Kim VN . miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009; 16: 23\u201329.","journal-title":"Nat Struct Mol Biol"},{"key":"BFcdd2016146_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.mehy.2013.08.030","volume":"81","author":"H Xu","year":"2013","unstructured":"Xu H, Liu B . CPEB4 is a candidate biomarker for defining metastatic cancers and directing personalized therapies. Med Hypotheses 2013; 81: 875\u2013877.","journal-title":"Med Hypotheses"},{"key":"BFcdd2016146_CR23","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/hep.26941","volume":"59","author":"X Yang","year":"2014","unstructured":"Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ et al. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology 2014; 59: 1874\u20131885.","journal-title":"Hepatology"},{"key":"BFcdd2016146_CR24","doi-asserted-by":"publisher","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","volume":"9","author":"DG Altman","year":"2012","unstructured":"Altman DG, McShane LM, Sauerbrei W, Taube SE . Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 2012; 9: e1001216.","journal-title":"PLoS Med"},{"key":"BFcdd2016146_CR25","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1073\/pnas.0511155103","volume":"103","author":"JM Cummins","year":"2006","unstructured":"Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr., Sjoblom T et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687\u20133692.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2016146_CR26","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","volume":"104","author":"M Fabbri","year":"2007","unstructured":"Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3\u2009A and 3B. Proc Natl Acad Sci USA 2007; 104: 15805\u201315810.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2016146_CR27","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.1073\/pnas.0801130105","volume":"105","author":"S Sengupta","year":"2008","unstructured":"Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 2008; 105: 5874\u20135878.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2016146_CR28","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","volume":"67","author":"KP Porkka","year":"2007","unstructured":"Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T . MicroRNA expression profiling in prostate cancer. Cancer Res 2007; 67: 6130\u20136135.","journal-title":"Cancer Res"},{"key":"BFcdd2016146_CR29","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065\u20137070.","journal-title":"Cancer Res"},{"key":"BFcdd2016146_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejcb.2012.11.004","volume":"92","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang X, Li H, Yu J, Ren X . The role of miRNA-29 family in cancer. Eur J Cell Biol 2013; 92: 123\u2013128.","journal-title":"Eur J Cell Biol"},{"key":"BFcdd2016146_CR31","first-page":"1382","volume":"7","author":"X Zhao","year":"2015","unstructured":"Zhao X, Li J, Huang S, Wan X, Luo H, Wu D . MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer. Am J Transl Res 2015; 7: 1382\u20131389.","journal-title":"Am J Transl Res"},{"key":"BFcdd2016146_CR32","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/annonc\/mdv302","volume":"26","author":"I Cristobal","year":"2015","unstructured":"Cristobal I, Madoz-Gurpide J, Manso R, Rojo F, Garcia-Foncillas J . MiR-29c downregulation contributes to metastatic progression in colorectal cancer. Ann Oncol 2015; 26: 2199\u20132200.","journal-title":"Ann Oncol"},{"key":"BFcdd2016146_CR33","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590\u201311593.","journal-title":"Cancer Res"},{"key":"BFcdd2016146_CR34","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1371\/journal.pbio.0030085","volume":"3","author":"J Brennecke","year":"2005","unstructured":"Brennecke J, Stark A, Russell RB, Cohen SM . Principles of microRNA-target recognition. PLoS Biol 2005; 3: e85.","journal-title":"PLoS Biol"},{"key":"BFcdd2016146_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hep.27911","volume":"62","author":"ZC Wang","year":"2015","unstructured":"Wang ZC, Gao Q, Shi JY, Guo WJ, Yang LX, Liu XY et al. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition. Hepatology 2015; 62: 1201\u20131214.","journal-title":"Hepatology"},{"key":"BFcdd2016146_CR36","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1158\/1078-0432.CCR-15-1125","volume":"22","author":"S Loi","year":"2015","unstructured":"Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P et al. RAS\/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1\/PD-L1 immune checkpoint inhibitors. Clin Cancer Res 2015; 22: 1499\u20131509.","journal-title":"Clin Cancer Res"},{"key":"BFcdd2016146_CR37","doi-asserted-by":"publisher","first-page":"13916","DOI":"10.1073\/pnas.1508514112","volume":"112","author":"L Fabris","year":"2015","unstructured":"Fabris L, Berton S, Pellizzari I, Segatto I, D'Andrea S, Armenia J et al. p27kip1 controls H-Ras\/MAPK activation and cell cycle entry via modulation of MT stability. Proc Natl Acad Sci USA 2015; 112: 13916\u201313921.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2016146_CR38","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1016\/j.ejca.2013.07.149","volume":"49","author":"H Wang","year":"2013","unstructured":"Wang H, An H, Wang B, Liao Q, Li W, Jin X et al. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 2013; 49: 3924\u20133935.","journal-title":"Eur J Cancer"},{"key":"BFcdd2016146_CR39","first-page":"7","volume":"120","author":"KH Vousden","year":"2005","unstructured":"Vousden KH, Prives C . P53 and prognosis: new insights and further complexity. Cell 2005; 120: 7\u201310.","journal-title":"Cell"},{"key":"BFcdd2016146_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","volume":"26","author":"N Raver-Shapira","year":"2007","unstructured":"Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731\u2013743.","journal-title":"Mol Cell"},{"key":"BFcdd2016146_CR41","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","volume":"17","author":"GT Bommer","year":"2007","unstructured":"Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298\u20131307.","journal-title":"Curr Biol"},{"key":"BFcdd2016146_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.2540","volume":"18","author":"E Ortiz-Zapater","year":"2012","unstructured":"Ortiz-Zapater E, Pineda D, Martinez-Bosch N, Fernandez-Miranda G, Iglesias M, Alameda F et al. Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med 2012; 18: 83\u201390.","journal-title":"Nat Med"},{"key":"BFcdd2016146_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc3485","volume":"13","author":"A D'Ambrogio","year":"2013","unstructured":"D'Ambrogio A, Nagaoka K, Richter JD . Translational control of cell growth and malignancy by the CPEBs. Nat Rev Cancer 2013; 13: 283\u2013290.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd2016146_CR44","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-14-0960","volume":"74","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang LF, Wu J, Xu SJ, Xu YY, Li D et al. IL-1beta-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. Cancer Res 2014; 74: 4720\u20134730.","journal-title":"Cancer Res"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2016146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2016146","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2016146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:10:29Z","timestamp":1684415429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2016146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFcdd2016146"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2016.146","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]},"assertion":[{"value":"2 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}